# Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

> **NCT00003633** · PHASE1 · UNKNOWN · sponsor: **Herbert Irving Comprehensive Cancer Center** · enrollment: 12 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** estramustine phosphate sodium
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00003633
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003633, "Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*